DIHYDROERGOTAMINE TARTRATE CRYSTALLINE CAS 5989-77-5

Introduction：Basic information about DIHYDROERGOTAMINE TARTRATE CRYSTALLINE CAS 5989-77-5, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.

DIHYDROERGOTAMINE TARTRATE CRYSTALLINE Basic information

• Product Name: DIHYDROERGOTAMINE TARTRATE CRYSTALLINE
• Synonyms: 9,10-dihydroergotaminetartrate;dihydro-ergotamintartrate(2:1)(salt);bis[5'alpha-benzyl-9,10alpha-dihydro-12'-hydroxy-2'-methylergotaman-3',6',18-trione] [R-(R*,R*)]-tartrate;DIHYDROERGOTAMINETARTRATE[DD];Dihydroergotamintartrat;DIHYDROERGOTAMINE TARTRATE CRYSTALLINE;Dihydroergotamine tartrate (D1952000);Ergotaman-3′,6′,18-trione, 9,10-dihydro-12′-hydroxy-2′-methyl-5′-(phenylmethyl)-, (5′α,10α)-, (2R,3R)-2,3-dihydroxybutanedioate (2:1)
• CAS: 5989-77-5
• MF: 2C33H37N5O5.C4H6O6
• MW: 1317.46
• EINECS: 227-816-1
• Product Categories: Alkaloids;Biochemistry;Indole Alkaloids
• Mol File: 5989-77-5.mol

DIHYDROERGOTAMINE TARTRATE CRYSTALLINE Chemical Properties

• Melting point: 205 °C (decomp)(Solv: methanol, 95% (67-56-1))
• refractive index: -55 ° (C=1, Pyridine)
• solubility: Very slightly soluble in water, sparingly soluble in alcohol

Safety Information

• Hazard Codes: Xn
• Risk Statements: 20/21/22
• Safety Statements: 36
• RIDADR: 1544
• WGK Germany: 3
• RTECS: KE8000000
• HazardClass: 6.1(b)
• PackingGroup: III

DIHYDROERGOTAMINE TARTRATE CRYSTALLINE Usage And Synthesis

Chemical Properties

White or almost white, crystalline powder or colourless crystals.

Uses

Dihydroergotamine (+)-tartrate salt is a vascular serotonin receptor activator. In addition, it has been shown to induce lung cancer cell death through apoptosis and mitophagy.

Uses

Antimigraine;Serotonine antagonist

Definition

ChEBI: The L-(+)-tartaric acid salt of dihydroergotamine, a semisynthetic ergot alkaloid with weaker oxytocic and vasoconstrictor properties than ergotamine. Both the tartrate and the mesylate salts are used for the treatment of migraine and orthstatic hypotension.